We further confirmed the associations between Trx system and prognosis in pan-cancer by analyzing the expression of Trx system with overall survival (OS) and relapse-free survival (RFS) in malignancies of the bladder, head and neck, kidney, liver, and lung (Figure S3). This evidence concerns the gene TXN and cancer.